#Liquid Biopsy

Worldnewpaper24.com

The trailblazer in Hong Kong bioscience who embraced new know-how for detecting most cancers early – NEWPAPER24

The trailblazer in Hong Kong bioscience who embraced new know-how for detecting most cancers early. Stanley Sy Ming-yiu fears not treading his personal path. Simply when many scientists remained cautious of a brand new approach for testing blood samples to detect most cancers at an early stage, he determined to make the leap.Beneath his management, a group at Sanomics has invested their time closely in creating the applying of liquid biopsy, a comparatively novel various to the extra sophisticated strategy of surgically eradicating tissue from the physique for evaluation.In accordance with Sy, the brand new genetic-testing technique is…
Picture for The trailblazer in Hong Kong bioscience who embraced new know-how for detecting most cancers early – NEWPAPER24
TRENDING TOPICS
Cancerajmc.com

Liquid Biopsy Has Potential to Advance Precision Medicine in Melanoma

Years of research has shown that in cancers like melanoma, liquid biopsy enables the detection of biomarkers, such as circulating tumor cells, circulating tumor DNA, and exomes. Precision medicine has opened the door to more personalized treatments in melanoma, improving the odds of survival for patients with advanced stage of...
HealthBusiness Insider

SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies

LUND, Sweden and STOCKHOLM, June 29, 2021 /CNW/ -- SAGA Diagnostics AB ("SAGA"), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. The Series A2 round was led by Segulah Medical Acceleration and the Sciety investment syndicate with strong support from existing shareholders such as Hadean Ventures.
YOU MAY ALSO LIKE